These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32980194)

  • 21. Movement disorders and pregnancy: a review of the literature.
    Kranick SM; Mowry EM; Colcher A; Horn S; Golbe LI
    Mov Disord; 2010 Apr; 25(6):665-71. PubMed ID: 20437535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome.
    Reuter I; Ellis CM; Ray Chaudhuri K
    Acta Neurol Scand; 1999 Sep; 100(3):163-7. PubMed ID: 10478579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An update on new and unique uses of botulinum toxin in movement disorders.
    Jankovic J
    Toxicon; 2018 Jun; 147():84-88. PubMed ID: 28888928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associated movement disorders in orthostatic tremor.
    Mestre TA; Lang AE; Ferreira JJ; Almeida V; de Carvalho M; Miyasaki J; Chen R; Fox S
    J Neurol Neurosurg Psychiatry; 2012 Jul; 83(7):725-9. PubMed ID: 22577231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of hyperkinetic movement disorders.
    Bressman SB; Greene PE
    Neurol Clin; 1990 Feb; 8(1):51-75. PubMed ID: 2181268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current concepts in the management of movement disorders.
    Olanow CW
    Clin Neurosurg; 1981; 28():137-70. PubMed ID: 6119175
    [No Abstract]   [Full Text] [Related]  

  • 27. "Unvoluntary" Movement Disorders: Distinguishing between Tics, Akathisia, Restless Legs, and Stereotypies.
    Nilles C; Amorelli G; Pringsheim TM; Martino D
    Semin Neurol; 2023 Feb; 43(1):123-146. PubMed ID: 36854394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Genetic risk variants in Parkinson's disease and other movement disorders].
    Brockmann K; Lohmann K
    Nervenarzt; 2017 Jul; 88(7):713-719. PubMed ID: 28536875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pathophysiology of movement disorders.
    Marsden CD
    Neurol Clin; 1984 Aug; 2(3):435-59. PubMed ID: 6241955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Movement disorders in the psychiatric patient.
    Moros DA; Yahr MD
    Hosp Community Psychiatry; 1984 Apr; 35(4):377-83. PubMed ID: 6232196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum Toxin in Movement Disorders: An Update.
    Anandan C; Jankovic J
    Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33430071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restless Legs Syndrome in NKX2-1-related chorea: An expansion of the disease spectrum.
    Iodice A; Carecchio M; Zorzi G; Garavaglia B; Spagnoli C; Salerno GG; Frattini D; Mencacci NE; Invernizzi F; Veneziano L; Mantuano E; Angriman M; Fusco C
    Brain Dev; 2019 Mar; 41(3):250-256. PubMed ID: 30352709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drugs affecting movement disorders.
    Campanella G; Roy M; Barbeau A
    Annu Rev Pharmacol Toxicol; 1987; 27():113-36. PubMed ID: 2953302
    [No Abstract]   [Full Text] [Related]  

  • 34. Movement disorders in children: Tourette syndrome.
    Golden GS
    J Dev Behav Pediatr; 1982 Dec; 3(4):209-16. PubMed ID: 6961138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parkinsonism and other movement disorders in 23 cases of neurocysticercosis.
    Alarcón F; Cedeño Y; de Yébenes JG
    Parkinsonism Relat Disord; 2017 Sep; 42():47-53. PubMed ID: 28673613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Restless legs syndrome outside the blood-brain barrier--exacerbation by domperidone in Parkinson's disease.
    Rios Romenets S; Dauvilliers Y; Cochen De Cock V; Carlander B; Bayard S; Galatas C; Wolfson C; Postuma RB
    Parkinsonism Relat Disord; 2013 Jan; 19(1):92-4. PubMed ID: 22922159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical, Genetic, and Radiological Features of Extrapyramidal Movement Disorders in Mitochondrial Disease.
    Martikainen MH; Ng YS; Gorman GS; Alston CL; Blakely EL; Schaefer AM; Chinnery PF; Burn DJ; Taylor RW; McFarland R; Turnbull DM
    JAMA Neurol; 2016 Jun; 73(6):668-74. PubMed ID: 27111573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of restless legs syndrome, pain, and mood disorders in Parkinson's disease.
    Rana AQ; Qureshi AR; Rahman L; Jesudasan A; Hafez KK; Rana MA
    Int J Neurosci; 2016; 126(2):116-20. PubMed ID: 25469455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severity of restless legs syndrome is inversely correlated with echogenicity of the substantia nigra in different neurodegenerative movement disorders. a preliminary observation.
    Pedroso JL; Bor-Seng-Shu E; Felicio AC; Braga-Neto P; Dutra LA; de Aquino CC; Ferraz HB; do Prado GF; Teixeira MJ; Barsottini OG
    J Neurol Sci; 2012 Aug; 319(1-2):59-62. PubMed ID: 22632781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microdeletions detected using chromosome microarray in children with suspected genetic movement disorders: a single-centre study.
    Dale RC; Grattan-Smith P; Nicholson M; Peters GB
    Dev Med Child Neurol; 2012 Jul; 54(7):618-23. PubMed ID: 22515636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.